Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review)
Authors:
- LuqmaniLULuqmani
- Leyla H. SharafLSLeyla H. Sharaf
- Yunus A. LuqmaniYLYunus A. Luqmani
Open Access
- 1 May 2011
- journal article
- review article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 38 (5) , 1197-1217
Abstract
Both de novo and acquired endocrine resistance constitute a major therapeutic problem for treatment of hormone-positive breast cancer. Multiple explanatory mechanisms have been proposed through the study of cellular models which focus principally on receptor tyrosine kinase mediated signalling pathways utilizing SRC, PI3K, MAPK and WADS. Many of the transducing molecules, particularly nuclear transcription factors such as SNAIL, TWIST, SNAIL2, ZEB FOXC2, TCF/LEF and GOOSECOID are participants in proliferation as well as invasion and metastasis, involving a process of orchestrated cellular remodeling which is being likened to the process of epithelial to mesenchymal transition that takes place during embryonic development. We review the accumulating evidence that points towards the occurrence of this phenomenon as a consequence of the loss of endocrine control, with both processes being similarly characterized by depletion of cell adhesion proteins, E-cadherin, catenins and cytokeratins, increased association with the extracellular matrix through induction of metalloproteinases, fibronectin and collagen, and a switch to a mobile vimentin-based cytoskeletal structure with loss of apical basal polarity.Keywords
This publication has 156 references indexed in Scilit:
- Expression and splicing of the unfolded protein response gene XBP‐1 are significantly associated with clinical outcome of endocrine‐treated breast cancerInternational Journal of Cancer, 2008
- The basal‐like breast carcinoma phenotype is regulated by SLUG gene expressionThe Journal of Pathology, 2007
- Mechanisms of metastasis: Epithelial‐to‐mesenchymal transition and contribution of tumor microenvironmentJournal of Cellular Biochemistry, 2007
- Cell cycle control in breast cancer cellsJournal of Cellular Biochemistry, 2005
- Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylationInternational Journal of Cancer, 2005
- Fulvestrant versus anastrozole for the treatment of advanced breast carcinomaCancer, 2005
- Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinomaCancer, 2005
- DIRECT EVIDENCE FOR A ROLE OF β‐CATENIN/LEF‐1 SIGNALING PATHWAY IN INDUCTION OF EMTCell Biology International, 2002
- C‐myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cellsInternational Journal of Cancer, 2002
- Resistance to tamoxifen‐induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancerInternational Journal of Cancer, 2001